No photo of Daniel J Lodge

View Scopus Profile

Daniel J Lodge

  • 3265 Citations
  • 26 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daniel J Lodge is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Regulation of ventral hippocampal system function

Lodge, D. J.

National Institutes of Health

7/1/10 → 6/30/20

Project: Research project

    • Adiponectin regulation of the mesolimbic dopamine system

    Lu, X. & Lodge, D. J.

    National Institutes of Health

    2/22/12 → 1/31/15

    Project: Research project

    • Research Output

    Ketamine: Leading us into the future for development of antidepressants

    Carreno, F. R., Lodge, D. J. & Frazer, A., Apr 6 2020, In : Behavioural Brain Research. 383, 112532.

    Research output: Contribution to journal › Review article

    • Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility

    Perez, S. M. & Lodge, D. J., Dec 20 2019, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 95, 109701.

    Research output: Contribution to journal › Article

    • Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats

    Perez, S. M., Donegan, J. J. & Lodge, D. J., Apr 19 2019, In : Behavioural Brain Research. 362, p. 258-265 8 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Modulation of extrasynaptic GABAA alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner

    Donegan, J. J., Boley, A. M., Yamaguchi, J., Toney, G. M. & Lodge, D. J., Dec 1 2019, In : Nature communications. 10, 1, 2819.

    Research output: Contribution to journal › Article

    Open Access

    • Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia

    Perez, S. M., Boley, A. & Lodge, D. J., Dec 1 2019, In : Translational psychiatry. 9, 1, 264.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Press / Media

    University of Texas Health Science Center-San Antonio: Novel Gene Therapy Curbs Schizophrenia Symptoms

    Daniel J Lodge

    7/6/19

    1 item of Media coverage

    Press/Media: Press / Media

    University of Texas Health Science Center at San Antonio: Free Public Symposium Nov. 30 to Break Down Schizophrenia's Walls

    David A Morilak & Daniel J Lodge

    11/16/18

    1 item of Media coverage

    Press/Media: Press / Media

    Psychiatry's Brave New World--FDA Approves Digital Sensor in Antipsychotic Drug

    Daniel J Lodge

    1/15/18

    1 item of Media coverage

    Press/Media: Press / Media

    Psychiatry's Brave New WorldFDA Approves Digital Sensor in Antipsychotic Drug to Enforce Prescription Compliance

    Daniel J Lodge

    1/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    Psychiatry's Brave New World--FDA Approves Digital Sensor in Antipsychotic Drug to Enforce Prescription Compliance

    Daniel J Lodge

    1/11/18 → 1/12/18

    45 items of Media coverage

    Press/Media: Press / Media